<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01809197</url>
  </required_header>
  <id_info>
    <org_study_id>M-12-056</org_study_id>
    <nct_id>NCT01809197</nct_id>
  </id_info>
  <brief_title>Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution</brief_title>
  <official_title>Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare lens comfort on Day 30 for Air Optix® lenses cared
      for with OPTI-FREE® PureMoist® (OFPM) Multi Purpose Disinfecting Solution (MPDS) compared to
      Acuvue® Oasys® lenses cared for with habitual MPDS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior to the 30-day study period, subjects were fitted with study lenses in a masked manner
      and underwent a run-in period of 4-8 days to adjust to the randomized lenses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Likert Scale Questionnaire Item: &quot;I Can Comfortably Wear my Lenses&quot;</measure>
    <time_frame>Day 30; after 4 hours of lens wear</time_frame>
    <description>Response of subject to a questionnaire item using a 5-point Likert scale, where 5=strongly agree and 1=strongly disagree.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">387</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Air Optix/OFPM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acuvue Oasys/Habitual MPS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lotrafilcon B contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for near/far-sightedness, astigmatism, and/or presbyopia, replaced per manufacturer's instructions</description>
    <arm_group_label>Air Optix/OFPM</arm_group_label>
    <other_name>AIR OPTIX® AQUA</other_name>
    <other_name>AIR OPTIX® AQUA Multifocal</other_name>
    <other_name>AIR OPTIX® for Astigmatism</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Senofilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for near/far-sightedness, astigmatism, and/or presbyopia, replaced per manufacturer's instructions</description>
    <arm_group_label>Acuvue Oasys/Habitual MPS</arm_group_label>
    <other_name>ACUVUE® OASYS® with HYDRACLEAR® PLUS</other_name>
    <other_name>ACUVUE® OASYS® for ASTIGMATISM with HYDRACLEAR® PLUS</other_name>
    <other_name>ACUVUE® OASYS® for PRESBYOPIA with HYDRACLEAR® PLUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS)</intervention_name>
    <description>Multi-purpose disinfecting solution for contact lens care, used per manufacturer's instructions</description>
    <arm_group_label>Air Optix/OFPM</arm_group_label>
    <other_name>OPTI-FREE® PureMoist™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Habitual Multi-Purpose Solution (MPS)</intervention_name>
    <description>Multi-purpose solution for contact lens care according to subject's habitual brand, used per manufacturer's instructions</description>
    <arm_group_label>Acuvue Oasys/Habitual MPS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign informed consent.

          -  Currently wearing weekly/monthly contact lenses on a daily wear basis, as specified in
             protocol.

          -  Willing to wear contact lenses on a daily wear basis for the duration of the study.

          -  Currently using a multi-purpose solution, as specified in protocol.

          -  Vision correctable to 20/30 (Snellen) or better in each eye at distance at Visit 1.

          -  Willing to follow the study procedures and visit schedule.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Currently wearing Air Optix, Acuvue Oasys, or Acuvue Advance brand of lenses.

          -  Currently using any Opti-Free brand of multi-purpose solution.

          -  Must wear contact lenses on an extended wear (overnight) basis during the study.

          -  Known sensitivity or intolerance to POLYQUAD® or ALDOX preserved lens care products.

          -  Monocular (only one eye with functional vision), fit with only one lens, or monovision
             modality of wear.

          -  Use of additional lens care products other than a multi-purpose solution within 7 days
             prior to Visit 1.

          -  Use of topical ocular over-the-counter (OTC) or prescribed topical ocular medications,
             with the exception of contact lens rewetting drops, within 7 days prior to Visit 1.

          -  Any abnormal ocular condition observed during the Visit 1 slit-lamp examination.

          -  Current or history of ocular infections (i.e., microbial keratitis, conjunctivitis) or
             severe inflammation (i.e., iritis, infiltrates) within the 6 months prior to Visit 1.

          -  Ocular surgery within the 12 months prior to Visit 1.

          -  Any systemic diseases at Visit 1 (including allergies, respiratory infections or
             colds) that affect the eye and could be exacerbated by use of contact lenses or
             contact lens solutions.

          -  Participation in any clinical study within 30 days of Visit 1.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessie Lemp, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2013</study_first_submitted>
  <study_first_submitted_qc>March 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2013</study_first_posted>
  <results_first_submitted>June 25, 2014</results_first_submitted>
  <results_first_submitted_qc>June 25, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 22, 2014</results_first_posted>
  <last_update_submitted>June 25, 2014</last_update_submitted>
  <last_update_submitted_qc>June 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Refractive error</keyword>
  <keyword>Myopia</keyword>
  <keyword>Hyperopia</keyword>
  <keyword>Astigmatism</keyword>
  <keyword>Presbyopia</keyword>
  <keyword>Contact lenses</keyword>
  <keyword>Contact lens solution</keyword>
  <keyword>Comfort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from 22 study sites located in the US.</recruitment_details>
      <pre_assignment_details>Of the 387 enrolled, 15 subjects were exited as screen failures prior to randomization. This reporting group includes all randomized subjects (372).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Air Optix/OFPM</title>
          <description>Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
        </group>
        <group group_id="P2">
          <title>Acuvue Oasys/Habitual MPS</title>
          <description>Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="187"/>
                <participants group_id="P2" count="185"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="177"/>
                <participants group_id="P2" count="177"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed slit lamp exam</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-Compliance</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Decision Unrelated to an Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Product not available</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all subjects who were randomized and received study regimen (test or control). Note: 1 subject randomized to Acuvue Oasys was not dispensed with study lenses.</population>
      <group_list>
        <group group_id="B1">
          <title>Air Optix/OFPM</title>
          <description>Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
        </group>
        <group group_id="B2">
          <title>Acuvue Oasys/Habitual MPS</title>
          <description>Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="187"/>
            <count group_id="B2" value="184"/>
            <count group_id="B3" value="371"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.4" spread="10.12"/>
                    <measurement group_id="B2" value="35.0" spread="11.14"/>
                    <measurement group_id="B3" value="33.7" spread="10.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Likert Scale Questionnaire Item: &quot;I Can Comfortably Wear my Lenses&quot;</title>
        <description>Response of subject to a questionnaire item using a 5-point Likert scale, where 5=strongly agree and 1=strongly disagree.</description>
        <time_frame>Day 30; after 4 hours of lens wear</time_frame>
        <population>This analysis population includes all subjects who were randomized and received study regimen (test or control) with a Day 30 response to this Likert item.</population>
        <group_list>
          <group group_id="O1">
            <title>Air Optix/OFPM</title>
            <description>Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
          </group>
          <group group_id="O2">
            <title>Acuvue Oasys/Habitual MPS</title>
            <description>Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
          </group>
        </group_list>
        <measure>
          <title>Likert Scale Questionnaire Item: &quot;I Can Comfortably Wear my Lenses&quot;</title>
          <description>Response of subject to a questionnaire item using a 5-point Likert scale, where 5=strongly agree and 1=strongly disagree.</description>
          <population>This analysis population includes all subjects who were randomized and received study regimen (test or control) with a Day 30 response to this Likert item.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="0.90"/>
                    <measurement group_id="O2" value="4.4" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for duration of study (3 months). This analysis group includes all subjects who were randomized and received study regimen (test or control). Note: 1 subject randomized to Acuvue Oasys was not dispensed study lenses.</time_frame>
      <desc>An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users or other persons, whether or not related to the medical device. AE data were collected at each study visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Air Optix/OFPM</title>
          <description>Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system</description>
        </group>
        <group group_id="E2">
          <title>Acuvue Oasys/Habitual MPS</title>
          <description>Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="187"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="187"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jessie Lemp, GMA Brand Lead - Vision Care</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

